Haemonetics Corporation (HAE)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
$5.57B
EV to revenue ratio (TTM)
4.52
EV to ebitda
21.80
Financial Performance
Revenue (TTM)
$1.38B
Gross profit (TTM)
$0.83B
EBITDA
$0.36B
Profitability
Operating margin (TTM)
21.60%
Profit margin
7.52%
Return on assets (TTM)
6.71%
Return on equity (TTM)
11.90%
Per Share Metrics
Revenue per share (TTM)
$30.07
EPS
$2.26
Diluted EPS (TTM)
$2.26
Book value
$19.74
Dividend per share
n/a
Dividend yield
n/a
Valuation Multiples
P/E ratio
54.14
Trailing P/E
54.14
Forward P/E
22.47
PEG ratio
1.87
Price to sales ratio (TTM)
4.03
Price to book ratio (TTM)
5.99
Growth
Quarterly earnings growth (YoY)
9.30%
Quarterly revenue growth (YoY)
23.50%
Analyst Sentiment
Strong buy
4
Buy
5
Hold
2
Sell
0
Strong sell
0
Risk & Volatility
Beta
0.59